JAB-2485

· Jacobio Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JAB-2485, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: JAB-2485 Activity in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]